Table 3.
(a) Diffusion measurements of healthy volunteers
| |||||||
---|---|---|---|---|---|---|---|
Sequence | b-values group | Mono-exponential | Kurtosis | ||||
ADC×10−3(mm2/s) | Dk×10−3 (mm2/s) | k | |||||
CG | PZ | CG | PZ | CG | PZ | ||
ssEPI | Low | 1.34±0.09 | 1.38±0.26 | 1.57±0.17 | 1.64±0.24 | 0.79±0.24 | 0.92±0.30 |
High | 1.24±0.09 | 1.29±0.27 | 1.59±0.17 | 1.68±0.31 | 0.76±0.10 | 0.81±0.16 | |
rFOV | Low | 1.33±0.09 | 1.39±0.15 | 1.59±0.18 | 1.67±0.22 | 0.86±0.36 | 0.85±0.37 |
High | 1.20±0.10 | 1.29±0.25 | 1.59±0.15 | 1.74±0.25 | 0.84±0.11 | 0.87±0.19 | |
msEPI | Low | 1.32±0.14 | 1.33±0.21 | 1.62±0.22 | 1.59±0.29 | 0.98±0.42 | 0.86±0.43 |
High | 1.23±0.14 | 1.24±0.22 | 1.53±0.23 | 1.57±0.24 | 0.70±0.15 | 0.76±0.12 |
(b) ADC measurements in patients (×10−3 mm2/s)
| ||
---|---|---|
Sequence | Central Gland (including BPH) | Healthy Peripheral Zone |
ssEPI | 1.29±0.17 | 1.74±0.23 |
rFOVs | 1.27±0.15 | 1.58±0.22 |
rFOVl | 1.31±0.16 | 1.68±0.21 |
msEPI | 1.26±0.17 | 1.73±0.29 |
CG: Central gland; PZ: Peripheral zone.
Low b-values group is b = [10, 50, 100, 200, 400, 600, 800] s/mm2;
High b-values group is b = [10, 50, 100, 400, 800, 1200, 1500] s/mm2.